“Last year, we had only one cell therapy product on the market and ranked 12th in the world, but this year we have reached eighth place in the world with 5 products,” according to Mostafa Qanei, an ...

Life can feel overwhelming sometimes. When you’re caught in cycles of overthinking or struggling to find balance, it’s easy to feel stuck and unsure of where to turn. At In Progress Therapy, we ...

LONDON - Spur Therapeutics, a portfolio company of Syncona Ltd, has announced encouraging new data from its gene therapy programs targeting Gaucher disease, GBA1 Parkinson’s disease, and ...